Mobile Logo in White

Filter News

AAMC News: Five ways that clinical trials might change for good

May 21, 2021

Dr. Ruben Mesa, executive director of the Mays Cancer Center, is quoted in this excellent AAMC story about five ways that clinical trials may have changed for good, thanks to COVID-19’s forcing researchers to try new ways of running clinical trials. Re …


KSAT 12: Q&A: Dr. Berggren discusses effectiveness of COVID-19 vaccines against other variants

May 21, 2021

Dr. Ruth Berggren, Infectious Diseases, discussed the effectiveness of the COVID-19 vaccine against other variants during KSAT 12’s Q&A segment. She also said elderly people should still be careful in crowds and wear masks in doctor’s offices. Watc …


KENS 5: Recommended age for colorectal cancer screenings lowered to 45

May 21, 2021

Dr. Alicia Logue, colon and rectal cancer surgery specialist from the Mays Cancer Center for patient care services within the UT Health San Antonio MD Anderson Cancer Center, spoke to KENS 5 viewers about why the age change for screening is important i …


MSN.com: Recommended age for colorectal cancer screenings lowered to 45

May 21, 2021

Dr. Alicia Logue, colon and rectal cancer surgery specialist from the Mays Cancer Center for patient care services within the UT Health San Antonio MD Anderson Cancer Center, spoke to KENS 5 viewers about why the age change for screening is important i …


HPV oncoprotein

Mays Cancer Center, home to UT Health San Antonio MD Anderson, and other top U.S. cancer centers call for action to get cancer-preventing HPV vaccination back on track

May 20, 2021

The COVID-19 pandemic has interrupted delivery of key health services for children and adolescents, including HPV vaccination for cancer prevention.      Contact: Will Sansom, (210) 567-2579, sansom@uthscsa.edu   SAN ANTONIO, May 20, 2021 –   …


News-Medical.net: Four months of multi-drug therapy for tuberculosis is as effective as standard regimen

May 20, 2021

Four months of multi-drug therapy that included rifapentine and moxifloxacin treated active tuberculosis (TB) as effectively as the standard six-month regimen in a multinational study, cutting treatment time by a third. Coauthors including Marc Weiner, …


Fox 29: New technology paves the way to identify sneaky cancer

May 20, 2021

Dr. Robert Svatek, urologist from the Mays Cancer Center for patient care services within the UT Health San Antonio MD Anderson Cancer Center, did a four-minute, live segment on Fox 29 San Antonio (KABB-TV) to raise awareness about bladder cancer. Dr. …


Farewell to Our Focus

May 19, 2021

It is time to discontinue this newsletter that was created to chronicle our COVID-19 response. However, our university news coverage, including COVID-19 updates, will continue in our weekly campus newsletter, This Week.


KGNS-TV: Thousands of Texans skipping out on second dose

May 19, 2021

Dr. Jessica Solis-McCarthy, Emergency Medicine, is quoted in this KGNS TV (Laredo) story about people who are missing their second COVID-19 dose or choosing to not get it. She believes that transportation, accessibility and fear/concern of side effects …


Tuberculosis infographic

Study validates shorter treatment for major world infection, tuberculosis

May 19, 2021

Contact: Will Sansom, (210) 567-2579, sansom@uthscsa.edu SAN ANTONIO (May 19, 2021) — Four months of multi-drug therapy that included rifapentine and moxifloxacin treated active tuberculosis (TB) as effectively as the standard six-month regimen in a mu …


Showing page: 284

Filter news

Secured By miniOrange